Globalization of Ayurveda pharmaceutics: Emerging trends

This article reviews contemporary initiatives to build Ayurveda as a global holistic health care system. India is a forerunner in this medical system. Growing desire for natural and organic products with minimal side effects, more consumer awareness, and a surge in demand for nature-derived cosmetics and day care products, are expanding its attractiveness as a medical tourist destination around the world. Furthermore, with a growth in demand for natural products, FMCG products with natural components are grabbing consumer’s attention. Despite a drop in economic activity in 2020 owing to the pandemic, the ayurvedic industry is expected to reach $20.6 billion in 2021 and $23.3 billion in 2022, as per trade analysts. The current Covid scenario has prepared the way for Ayurveda to be eminent on the global healthcare map. In terms of global share, India has risen faster in the AYUSH market, accounting for approximately 2.8% of the market. Government investments and policies, Global market outreach, Evidence-based Study, Increased R&D expenditure, Innovations and startups, and Marketing to Millennials and Gen Z are the key factors to strongly with-hold the presence of this sector in the pharmaceutical world. Through its unique holistic healthcare approach, AYUSH along with Yoga holds the potential to make India a global healthcare leader. The AYUSH healthcare system will be increasingly important in the future decade, both domestically and globally.